about
Issues for consideration in the analysis of microarray data in behavioural studies.Unpredictable neonatal stress enhances adult anxiety and alters amygdala gene expression related to serotonin and GABA.Medial prefrontal cortex processes threatening stimuli in juvenile rats.Peripheral nerve graft with immunosuppression modifies gene expression in axotomized CNS neurons.Opiate withdrawal during development: are NMDA receptors indispensable?Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia.Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation.The role of the medial prefrontal cortex in innate fear regulation in infants, juveniles, and adolescents.Enduring good memories of infant trauma: rescue of adult neurobehavioral deficits via amygdala serotonin and corticosterone interaction.Effects of COX inhibition and LPS on formalin induced pain in the infant ratTransitions in infant learning are modulated by dopamine in the amygdala.Developmental Changes in Pain and Spinal Immune Gene Expression after Radicular Trauma in the Rat.Long-Term Effects of Chronic Buspirone during Adolescence Reduce the Adverse Influences of Neonatal Inflammatory Pain and Stress on Adaptive Behavior in Adult Male Rats.Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.Interactions between glia, the immune system and pain processes during early development.Repeated recall and PKMĪ¶ maintain fear memories in juvenile rats.Opiate withdrawal in the infant.Formalin-induced c-fos expression in the brain of infant rats.Spinal cord ionotropic glutamate receptors function in formalin-induced nociception in preweaning rats.Classical conditioning, decay and extinction of cocaine-induced hyperactivity and stereotypy.Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.Conditioned place preference from ventral tegmental injection of morphine in neonatal rats.Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.Analgesic efficacy of ketorolac and morphine in neonatal rats.Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.Mu opioid receptors in the ventrolateral periaqueductal gray mediate stress-induced analgesia but not immobility in rat pups.The role of opioid receptors in morphine withdrawal in the infant rat.Differential effects of specific opioid receptor agonists on rat pup isolation calls.Aversive properties of the kappa opioid agonist U50,488 in the week-old rat pup.The ontogeny of opioid receptors mediating opiate-induced feeding in rats.Developmental changes in the behavioral and autonomic effects of kappa opioid receptor stimulation of the midbrain periaqueductal gray.The development of cholecystokinin in the interpeduncular nucleus of rats.Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat.Mother lowers glucocorticoid levels of preweaning rats after acute threat.The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats.Age-specific threats induce CRF expression in the paraventricular nucleus of the hypothalamus and hippocampus of young rats.Opiate withdrawal in the fetal rat: a behavioral profile.Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats.Mapping of pain circuitry in early post-natal development using manganese-enhanced MRI in rats.Differences in the level of dopamine in the hypothalamus of aggressive and non-aggressive rats.
P50
Q30987945-06EE5AC8-2941-40A0-B304-8A1B4B36C204Q33731680-AD232370-A55E-460E-97D1-F9D2A874E666Q33764278-EF17536C-7EF0-41D9-A7E5-3993638FAF67Q33975087-8EA3E7B0-1400-430E-9E88-41E8BBD8EF91Q34322722-CE5C4AC6-A06B-4BF2-8AAC-A4D1C6F256CDQ34745631-70C2AA31-5C05-49D3-BB05-B4F00AA07D26Q34785692-3344BA45-F91A-4582-B2CE-7FBCA1725F3FQ35025744-AE36C609-B056-4FF6-8450-8051834869C0Q35031333-56F9B72E-181F-4713-8CCC-C36629D3232AQ35185830-8150D89D-56CC-4C36-BDB7-10BAAD696FD8Q37438375-874E6052-1D93-4BB6-B45F-081654953374Q37503843-280D7A59-4A69-4CC2-BA45-1DFA52EE4D14Q37607158-479DD3BC-9D69-40A8-9CCE-A5CA60565993Q38079201-1D437D57-EF25-4A1A-ACB3-E2113725378EQ38218630-6C83F630-358C-42B4-B9E7-CE548E7179A6Q39130595-40C770CA-49C0-46E1-B0FC-D7B4039E82A6Q40683985-8CCB5083-ABA0-4CA0-BFB4-67AC97144ECDQ42022201-B86F1827-30B8-4D38-8FE7-4EAF8FD969C6Q42172093-88546627-32B5-4156-A9A9-AA996E739BB9Q42254955-8B1911D7-279C-49FF-A86F-F1415AB216E3Q43285939-A3E916E1-43BF-47ED-A427-2C1F1006D852Q43462946-0C3F110D-770F-43FC-8E50-F778F279D544Q43579998-D0AA8D04-CBE6-4472-AB26-8FA748D28050Q43722632-416A1095-2C0F-414E-BA07-62AA15D547E1Q43890425-28EBA9C6-C2B1-4450-BAFD-C4C5182A28C5Q44330749-D29FE405-8C39-48B8-882B-B8F1C068BE6DQ44334078-49E63F3E-FC6F-4A72-A366-C2275DD5DED2Q44334619-53FEA9E3-7C62-474D-B244-F99FA0AC69D3Q44335889-D5B7E319-14AD-46C5-AA62-0B0B61AFFCE0Q44338195-51818E6C-A674-415E-9DC0-3009F366CD9CQ44347967-49216957-838F-4EBB-AA2F-A5EF59722A37Q44357516-D0480BF8-030B-468F-B75A-527745B44CB5Q44555307-73655EAF-CD9A-4C06-BC09-492FFFC82A0FQ44785324-3DC47755-6DAA-46B7-9AB7-95B574D36F97Q45068793-160EE2CF-E6B9-4DEA-B136-6C8020F7603AQ45233371-2C7550EC-CF95-4E4B-AE66-8A9DFEF5383AQ46354699-050F3EBC-244A-4053-BE2E-077180D746FFQ46780950-C85F80BE-E6E4-4963-8A77-326D39082C06Q47894416-7166D749-8269-483B-A359-A986840F7927Q48088759-70E9A158-0045-4A9A-8E54-9E81311CC8B4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
Õ°Õ„ÕæÕ”Õ¦ÕøÕæÕøÕ²
@hy
name
Gordon A. Barr
@ast
Gordon A. Barr
@en
Gordon A. Barr
@es
Gordon A. Barr
@nl
Gordon A. Barr
@sl
type
label
Gordon A. Barr
@ast
Gordon A. Barr
@en
Gordon A. Barr
@es
Gordon A. Barr
@nl
Gordon A. Barr
@sl
prefLabel
Gordon A. Barr
@ast
Gordon A. Barr
@en
Gordon A. Barr
@es
Gordon A. Barr
@nl
Gordon A. Barr
@sl
P1053
N-1288-2013
P106
P1153
7102234806
P21
P31
P3829
P496
0000-0003-4751-9937